ERIS · Concall Summary
ERIS LIFESCIENCES LIMITED
Concall2026-08-04
Tone: NeutralEris Lifesciences Limited announced that the transcript of the Analyst and Investor call, which took place following the financial results announcement for the quarter ended June 30, 2026, is now available on their website. The document provided the relevant URL for accessing the transcript and included details about the company's compliance officer. Management communicated this information formally to both the BSE and NSE.
The document conveyed factual information regarding the availability of the earnings call transcript.
View source filing →Earlier concalls
- 2026-07-29 — Eris Lifesciences Limited reported financial highlights for Q1 FY27, showing a 14.2% year-over-year increase in revenue …
- 2026-05-26 — The document is a notification from Eris Lifesciences Limited regarding the availability of the transcript for the Analy…
- 2026-02-20 — Eris Lifesciences Limited announced that the transcript of the Analyst and Investor call, which took place following the…
See ERIS's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.
Sign up free